The palmitoylation of the envelope protein possibly serves as an antiviral strategy in host cells, as ZIKV infections were enhanced following treatment with the palmitoylation inhibitor, 2-BP. The gene discussed is ERVW-1; the disease is Zika virus infectious disease.